Skip to main content

Series B Therapeutics Companies

Explore 188 therapeutics startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
188
Total Funding
$1.6B
Avg Funding
$62.3M
Cities
22

Export 188 Series B Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cambridge, United States
$38.0M
raised

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Bottmingen, Switzerland
$119.7M
raised

Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.

Dec 2021
Series B

Founder Contacts

30,000+ verified contacts

Malvern, United States
$6.9M
raised

MAXONA is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.

Dec 2022
Series B

Founder Contacts

30,000+ verified contacts

Waltham, United States
$103.0M
raised

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Dec 2021
Series B

Founder Contacts

30,000+ verified contacts

New York, United States

Ophelia offers medication and support for quitting opioids.

Dec 2021
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Elizabethtown, United States
$13.0M
raised

BehaVR develops evidence-based, immersive, digital therapeutics for behavioral health using Virtual Reality.

Dec 2022
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$130.0M
raised

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

Cincinnati, United States
$25.0M
raised

Alphyn Biologics is a life science company that develops Multi-Target Therapeutics (MTT) for effective treatment of skin diseases.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$84.0M
raised

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

Paris, France
$17.4M
raised

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Seattle, United States
$105.0M
raised

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

London, United Kingdom
$100.0M
raised

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

Washington, United States
$9.0M
raised

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

Jan 2024
Series B

Founder Contacts

30,000+ verified contacts

Milano, Italy
$141.0M
raised

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Nov 2025
Series B

Founder Contacts

30,000+ verified contacts

Mont-saint-guibert, Belgium
$23.4M
raised

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

Nov 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Atlanta, United States
$75.0M
raised

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$250.0M
raised

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

New York, United States
$91.0M
raised

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Geleen, The Netherlands
$11.3M
raised

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 188 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Palo Alto, United States
$73.1M
raised

Cognoa is a behavioral health company.

Nov 2022
Series B

Founder Contacts

30,000+ verified contacts

Newton, United States
$29.2M
raised

Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

Boston, United States
$103.0M
raised

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Osaka, Japan
$6.9M
raised

Alpha Fusion is a clinical research company that focuses on cancer treatment through the design and development of radiopharmaceuticals.

Oct 2024
Series B

Founder Contacts

30,000+ verified contacts

$3.6M
raised

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

Oct 2025
Series B

Founder Contacts

30,000+ verified contacts

Showing 151 to 175 of 188 companies

Ready to Connect with Series B Therapeutics Startups?

Get verified founder emails, funding details, and company data for 188 series b therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked